3-(3-bromophenyl)-2-methylpropionic acid | 849831-52-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: 3-(3-bromophenyl)-2-methylpropionic acid
• 英文别名: (2S)-3-(3-bromophenyl)-2-methylpropanoic acid
• CAS: 849831-52-3
• 化学式: C₁₀H₁₁BrO₂
• 分子量: 243.1
• InChiKey: WAXFQFBSRDYONP-ZETCQYMHSA-N

物化性质

• 沸点：
  340.2±17.0 °C(Predicted)
• 密度：
  1.460±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(3-bromophenyl)-2-methylpropionic acid 在 palladium diacetate sodium azide 、 TEA 、 1,3-双(二苯基膦)丙烷 、 potassium carbonate 、 (R)-CBS 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成 Benzyl (S)-1-(3-((R)-1-hydroxyethyl)phenyl)propan-2-ylcarbamate
  参考文献：
  名称：

  Comparative approaches toward diamines containing spatially separated homobenzylic and benzylic nitrogen stereocenters

  摘要：

  Several synthetic strategies to diamines 1-3 are described. The optimum approach via opening of aziridine afforded 1 3 in 29-60% yield over 3-5 steps. A study on formation of the benzylic stereocenter using Toste's rhenium-catalyzed asymmetric reduction of phosphinyl ketimines was also evaluated and afforded 15 in 92% de. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2007.05.073
• 作为产物：
  描述：

  (S)-3-(3-bromophenyl)-1-((R,Z)-4-isopropyl-2-(phenylimino)oxazolidin-3-yl)-2-methylpropan-1-one 在 sodium hydroxide 作用下， 以 1,4-二氧六环 为溶剂， 以93%的产率得到3-(3-bromophenyl)-2-methylpropionic acid
  参考文献：
  名称：

  Comparative approaches toward diamines containing spatially separated homobenzylic and benzylic nitrogen stereocenters

  摘要：

  Several synthetic strategies to diamines 1-3 are described. The optimum approach via opening of aziridine afforded 1 3 in 29-60% yield over 3-5 steps. A study on formation of the benzylic stereocenter using Toste's rhenium-catalyzed asymmetric reduction of phosphinyl ketimines was also evaluated and afforded 15 in 92% de. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2007.05.073

文献信息

• Asymmetric Hydrogenation of α,β-Unsaturated Carboxylic Acids Catalyzed by Ruthenium(II) Complexes of Spirobifluorene Diphosphine (SFDP) Ligands
  作者：Xu Cheng、Jian-Hua Xie、Sheng Li、Qi-Lin Zhou

  DOI：10.1002/adsc.200606065

  日期：2006.7

  The ruthenium diacetate complexes ligated by chiral spirobifluorene diphosphines (SFDP) were very effective catalysts for the asymmetric hydrogenation of tiglic acid derivatives and α-methylcinnamic acid derivatives with high activities and excellent enantioselectivities (up to 98 % ee). The α-aryloxybutenoic acids can also be hydrogenated by these catalysts to provide the corresponding saturated α-aryloxybutanoic

  由手性螺二芴二膦（SFDP）连接的二乙酸钌络合物是非常有效的催化剂，用于对酸衍生物和α-甲基肉桂酸衍生物进行不对称氢化，具有高活性和出色的对映选择性（最高98％ee）。这些催化剂还可以将α-芳氧基丁烯酸加氢，以提供相应的饱和α-芳氧基丁酸，以高收率（89-93％）和对映选择性（高达95％ee）提供。在该反应中，配体SFDP与对位上的甲基团P -苯基环，得到最好的结果。
• ISOINDOLINONE AND PYRROLOPYRIDINONE DERIVATIVES AS AKT INHIBITORS
  申请人：Incyte Corporation

  公开号：US20130096144A1

  公开（公告）日：2013-04-18

  The present invention provides isoindolinone and pyrrolopyridinone derivatives, as well as their compositions and methods of use, that inhibit the activity of the serine/threonine kinase, Akt, and are useful in the treatment of diseases related to the activity of Akt including, for example, cancer and other diseases.

  本发明提供了异吲哚酮和吡咯吡啶酮衍生物，以及它们的组合物和使用方法，这些衍生物抑制丝氨酸/苏氨酸激酶Akt的活性，对于治疗与Akt活性相关的疾病，例如癌症和其他疾病，具有益处。
• THERAPEUTIC COMPOUNDS
  申请人：GILEAD SCIENCES, INC.

  公开号：US20140221417A1

  公开（公告）日：2014-08-07

  Compounds of formula I: or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.

  本发明公开了化学式I的化合物或其盐。还公开了包括化学式I的化合物的药物组合物，制备化学式I的化合物的方法，制备化学式I的有用中间体以及治疗Retroviridae病毒感染，包括由HIV病毒引起的感染的治疗方法。
• Highly Rigid Diphosphane Ligands with a Large Dihedral Angle Based on a Chiral Spirobifluorene Backbone
  作者：Xu Cheng、Qi Zhang、Jian‐Hua Xie、Li‐Xin Wang、Qi‐Lin Zhou

  DOI：10.1002/anie.200462072

  日期：2005.2.4
• US8895571B2
  申请人：——

  公开号：US8895571B2

  公开（公告）日：2014-11-25